31998 Federal Register / Vol. 63, No. 112 /Thursday, June 11, 1998 / Notices

The extent to which the applicant

describes the plans for using

surveillance data to develop and

implement programs to prevent birth

defects and/or activities to improve the

access of children with birth defects to

health services and early interventions.

Specific criteria include:

a. Plan for working with appropriate

partners in the State; and

b. Plan for using the surveillance data

to develop prevention or intervention

programs.

5. Organizational and program

personnel capability (15 percent)

The extent to which the applicant has

the experience, skills, and ability to

develop and improve birth defects

surveillance and use surveillance data

to develop prevention or intervention

programs. The adequacy of the present

staff and capability to assemble

competent staff to implement a birth

defects surveillance system and develop

programs for prevention or intervention.

The applicant shall identify, to the

extent possible, all current and potential

personnel who will work on this

cooperative agreement, including

qualifications and specific experience as

it relates to the requirements set forth in

this request.

6. Matching funds (5 percent)

The extent to which the applicant

proposes matching funds. Matching

funds may be contributions by the

recipient of at least five percent of

Federal funds awarded under this

program. The applicant should identify

and describe:

a. The amount expended during the

preceding year for birth defects

surveillance activities and birth defects

prevention and intervention activities.

These amounts will be used to establish

a baseline for current and future match

amounts; and

b. Sources of matching funds for the

project and the estimated amounts from

each.

7. Budget justification and adequacy

of facilities (not scored)

The budget will be evaluated for the

extent to which it is reasonable, clearly

justified, and consistent with the

intended use of the cooperative

agreement funds. The applicant shall

describe and indicate the availability of

facilities and equipment necessary to

carry out this project. Proposed

matching funds must be detailed in the

budget.

8. Human subject review (not scored)

The applicant must clearly state

whether or not human subjects will be

used in research and ensure that

adequate human subjects protections

will be implemented.

H. Other Requirements

An original and two copies of semiannual progress reports are required of

all grantees. Due dates for the semiannual reports will be established at the

time of award. Final financial status and

performance reports are required no

later than 90 days after the end of the

project period.

Send all reports to: David Elswick,

Grants Management Specialist, Grants

Management Branch, Procurement and

Grants Office, Centers for Disease

Control and Prevention (CDC), 255 East

Paces Ferry Road, NE., Room 300,

Mailstop E–13, Atlanta, Georgia 30305–

2209.

The following additional

requirements are applicable to this

program. For a complete description of

each, see Attachment 1 of the

application kit.

AR98–1 Human Subjects

Requirements

AR98–2 Requirements for Inclusion of

Women and Racial and Ethnic

Minorities in Research

AR98–7 Executive Order 12372

Review

AR98–9 Paperwork Reduction Act

Requirements

AR98–10 Smoke-Free Workplace

Requirements

AR98–11 Healthy People 2000

AR98–12 Lobbying Restrictions

I. Authority and Catalog of Federal

Domestic Assistance Number

This program is authorized under

sections 301(a), 311 and 317C of the

Public Health Service Act [42 U.S.C.

241(a), 243, and 247b–4], as amended.

The Catalog of Federal Domestic

Assistance number is 93.238.

J. Where to Obtain Additional

Information

A complete program description and

information on application procedures

are contained in the application

package. Business management

technical assistance may be obtained

from David C. Elswick, Grants

Management Specialist, Grants

Management Branch, Procurement and

Grants Office, Centers for Disease

Control and Prevention (CDC), 255 East

Paces Ferry Road, NE., Room 300,

Mailstop E–13, Atlanta, Georgia 30305,

telephone (404) 842–6630.

Programmatic technical assistance

may be obtained from Larry D. Edmonds

or Paula W. Yoon, State Services, Birth

Defects and Genetic Diseases Branch,

Division of Birth Defects and

Developmental Disabilities, National

Center for Environmental Health,

Centers for Disease Control and

Prevention (CDC), 4770 Buford Highway

NE., Mailstop F–45, Atlanta, Georgia

30341–3724, telephone (404) 488–7170.

Please refer to Announcement

Number 98051 when requesting

information and submitting an

application.

Dated: June 5, 1998.

Joseph R. Carter,

Acting Associate Director for Management

and Operations, Centers for Disease Control

and Prevention (CDC).

[FR Doc. 98–15543 Filed 6–10–98; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

[Announcement Number 98065]

Grant to Study a Healthy Home/Healthy

Community Intervention Notice of

Availability of Funds for Fiscal Year

1998

A. Purpose

The Centers for Disease Control and

Prevention (CDC) announces the

availability of fiscal year (FY) 1998

funds for a grant to evaluate the

effectiveness of a Healthy Homes/

Healthy Community intervention to

improve children’s health by addressing

environmental hazards in deteriorating

communities and inadequate housing.

This program addresses the Healthy

People 2000 priority areas of

Environmental Health, Educational and

Community-Based Programs, and

Maternal and Infant Health.

The purpose of this program is the

implementation and evaluation of an

intervention strategy in a target

neighborhood to prevent childhood

disease caused by health hazards in the

residential environment. This

intervention will be to bring to bear

private- and public-sector financing to

reduce multiple environmental hazards

and associated childhood morbidities at

the level of both individual home and

surrounding neighborhood.

B. Eligible Applicants

Applications may be submitted by

public and private nonprofit

organizations and by governments and

their agencies; that is universities,

colleges, research institutions, hospitals,

other public and private nonprofit

organizations, State and local

governments or their bona fide agent.

Note: Public Law 104–65 states that an

organization described in section 501(c)(4) of

the Internal Revenue Code of 1986 that
Federal Register / Vol. 63, No. 112 /Thursday, June 11, 1998 / Notices 31999

engages in lobbying activities is not eligible

to receive Federal funds constituting an

award, grant, cooperative agreement,

contract, loan, or any other form.

C. Availability of Funds

Approximately $100,000 is available

in FY 1998 to fund 1 award. It is

expected that the award will begin on or

about September 30, 1998, and will be

made for a 12-month budget period

within a project period of up to 3 years.

Funding estimates may change.

Use of Funds

• Applicants may enter into contracts

and consortia agreements and

understandings as necessary to meet the

requirements of the program and

strengthen the overall application.

• Grants funds may not be expended

for medical care and treatment or for

environmental remediation.

D. Cooperative Activities

The following are applicant

requirements:

1. A director with specific authority

and responsibility to carry out the

requirements of the project and has

demonstrated experience in conducting

relevant epidemiologic studies,

including publication of original

research in peer-reviewed journals.

2. Design, implement and evaluate a

single strategy intervention which may

be based on the Community

Reinvestment Act (CRA), a Federal law

requiring federally insured deposit

facilities (e.g. banks and thrift-deposit

agencies) to respond to identified credit

needs in low-income communities that

they serve. (To obtain information on

CRA see WHERE TO OBTAIN

ADDITIONAL INFORMATION.)

3. Evaluate and interpret the outcome

of the intervention, including, collecting

and analyzing data necessary to enable

measurement of these outcomes.

4. Disseminate research findings.

E. Application Content

Use the information in the

COOPERATIVE ACTIVITIES, OTHER

REQUIREMENTS, and EVALUATION

CRITERIA sections to develop the

application content. Your application

will be evaluated on the criteria listed,

so it is important to follow them in

laying out your program plan. The

narrative should be no more than 30

double-spaced pages, printed on one

side, with one inch margins, and

unreduced font.

Please prepare your application

following the instructions in the PHS

Form 398. The following are

requirements:

1. Research and intervention plan

including: The proposed activities

should be clearly described in terms of

need, scientific basis, target

neighborhood, financial institution

participation, expected interactions, and

anticipated outcomes.

2. A research plan (design and

methods) including hypothesis and

expected outcome, value to field, and

specific, measurable, and time-framed

objectives consistent with the proposed

intervention strategy. The applicant

must demonstrate that they have met

the CDC/ATSDR policy requirements

regarding the inclusion of women,

ethnic, and racial groups in the

proposed projects. This includes:

a. The proposed plan for the inclusion

of both sexes and racial and ethnic

minority populations for appropriate

representation;

b. The proposed justification when

representation is limited or absent;

c. A statement as to whether the

design of the study is adequate to

measure differences when warranted;

and

d. A statement as to whether the plans

for recruitment and outreach for study

participants include the process of

establishing partnerships with

community(ies) and recognition of

mutual benefits.

Human Subjects: If the proposed

research involves obtaining data

through intervention or interaction with

an individual(s) or identifiable private

information, then the applicant must

provide background information on the

precautions that will be put in place to

protect human subjects.

3. Plans to collect baseline and postintervention measures of environmental

hazards, for example, the number of

residential units in a defined

neighborhood with specified hazards.

4. Plans to collect baseline and postintervention measures of specified

health effects among children (e.g.,

hospital admissions for asthma or

specified injuries, reports of rat bites,

elevated blood lead levels, pesticide or

other household poisonings).

5. Evidence of effective and welldefined working relationships within

the performing organization and with

outside entities which will ensure

implementation of the proposed study.

6. Evidence of access to a laboratory

with necessary proficiency in

performing environmental and biologic

laboratory measurements as required by

the proposed study protocol.

7. Plans to ensure that children

identified with health conditions

associated with environmental hazards

are referred for appropriate medical and

environmental management. If the

applicant does not have direct

responsibility for such activities, a letter

of support from the organization with

that responsibility is required.

8. Evidence of ability to identify and

gain access to a neighborhood with

demonstrated environmental hazards

and associated childhood morbidities

among residents, and to collect

appropriate environmental and biologic

data.

9. Evidence that a deposit facility

(bank or thrift) that is subject to the

provisions of the Community

Reinvestment Act has agreed to

participate in the intervention strategy.

F. Application Submission and

Deadline

Submit the original and five copies of

PHS Form 398 (Revised 5/95, OMB

Control Number 0925–0001) (adhere to

the instructions on the Errata

Instruction Sheet for PHS Form 398).

Forms are in the application kit. On or

before August 10, 1998, submit the

application to: Lisa T. Garbarino, Grants

Management Specialist, Grants

Management Branch, Procurement and

Grants Office, Announcement Number

98065, Centers for Disease Control and

Prevention (CDC), 255 East Paces Ferry

Road, NE., Room 300, Mailstop E–13,

Atlanta, Georgia 30305–2209.

If your application does not arrive in

time for submission to the independent

review group, it will not be considered

in the current competition unless you

can provide proof that you mailed it on

or before the deadline (i.e., a legibly

dated receipt from U.S. Postal Service or

a commercial carrier; private metered

postmarks are not acceptable).

G. Evaluation Criteria

Each application will be evaluated

individually against the following

criteria by an independent review group

appointed by CDC.

1. Research and Intervention Plan (50

Points)

a. Description of the intervention

strategy and how it will be implemented

that is sufficient to enable replication of

the intervention.

b. Evaluation plans; scientific

soundness (including description of

both hazard and health-effect outcomes

to be measured, adequate sample size

with power calculations), quality,

feasibility, consistency with the project

goals.

c. Access to suitable target

neighborhood and cooperation of a

financial institution.

2. Environmental, Educational, and

Medical Intervention (15 Points)

Ability to provide appropriate referral

for children identified as having the
32000 Federal Register / Vol. 63, No. 112 /Thursday, June 11, 1998 / Notices

environmental exposures specified in

the intervention.

3. Project Personnel (15 Points)

The qualifications, experience,

(including experience in conducting

relevant studies) and time commitment

of the staff needed to ensure

implementation of the project.

4. Laboratory Capacity (10 Points)

Documented availability of a

laboratory with demonstrated

proficiency in performing laboratory

measurements as indicated in

applicant’s proposed study.

5. Performance Measurement (10 Points)

Schedule for implementing and

monitoring the project. The extent to

which the application documents

specific, attainable, and realistic goals

and clearly indicates the performance

measures that will be monitored, how

they will be monitored, and with what

frequency.

6. Budget and Justification (Not Scored)

The budget will be evaluated for the

extent to which it is reasonable, clearly

justified, and consistent with the

intended use of cooperative agreement

funds.

7. Human Subjects (Not Scored)

If human subjects will be involved,

how will they be protected, i.e., describe

the review process which will govern

their participation. The applicant must

demonstrate that they have met the CDC

Policy requirements regarding the

inclusion of women, ethnic, and racial

groups in the proposed research. This

includes:

a. The proposed plan for the inclusion

of both sexes and racial and ethnic

minority populations for appropriate

representation;

b. The proposed justification when

representation is limited or absent;

c. A statement as to whether the

design of the study is adequate to

measure differences when warranted;

and

d. A statement as to whether the plans

for recruitment and outreach for study

participants include the process of

establishing partnerships with

community(ies) and recognition of

mutual benefits.

H. Other Requirements

Technical Reporting Requirements

Provide CDC with the original plus two

copies of

1. Annual progress reports including

the following for each goal or activity

involved in the study:

a. a comparison of actual

accomplishments to the goals

established for the period;

b. the reasons for slippage if

established goals were not met; and

c. other pertinent information and

data essential to evaluating progress.

2. Financial status report, no more

than 90 days after the end of the budget

period, and

3. Final financial report and

performance report no more than 90

days after the end of the project period.

Send all reports to: Lisa T. Garbarino,

Grants Management Specialist, Grants

Management Branch, Procurement and

Grants Office, Centers for Disease

Control and Prevention, (CDC), 255 East

Paces Ferry Road, NE., Room 300,

Mailstop E–13, Atlanta, Georgia 30305–

2209.

The following additional

requirements are applicable to this

program. For a complete description of

each, see Addendum 1 (included in the

application kit).

AR98–1 Human Subjects

Requirements

AR98–2 Requirements for Inclusion of

Women and Racial and Ethnic

Minorities in Research

AR98–9 Paperwork Reduction Act

Requirements

AR98–10 Smoke-Free Workplace

Requirements

AR98–11 Healthy People 2000

AR98–12 Lobbying Restrictions

I. Authority and Catalog of Federal

Domestic Assistance Number

This program is authorized under the

Public Health Service Act, Section

301(a) [42 U.S.C. section 241(a)], as

amended. The Catalog of Federal

Domestic Assistance number is 93.197.

J. Where To Obtain Additional

Information

To receive additional written

information call 1–888–GRANTS4 (1–

888–472–6874). You will be asked to

leave your name, organization, address,

and phone number and will need

Announcement Number 98065. All

application procedures and guidelines

are contained within that package or can

be found on the CDC Home Page. The

address for the CDC Home Page is

[http://www.cdc.gov].

Business management technical

assistance, contact: Lisa T. Garbarino,

Grants Management Specialist, Grants

Management Branch, Procurement and

Grants Office, Announcement Number

98065, Centers for Disease Control and

Prevention, (CDC), 255 East Paces Ferry

Road, NE., Room 300, Mailstop E–13,

Atlanta, Georgia 30305–2209,

Telephone: (404) 842–6796, E-mail

address: lgt1@cdc.gov.

For program technical assistance,

contact: Nancy Tips, National Center for

Environmental Health, Division of

Environmental Hazards and Health

Effects, Centers for Disease Control and

Prevention (CDC), 4770 Buford

Highway, NE., Room 1320, Mailstop F–

42, Atlanta, Georgia 30341, Telephone:

(770) 488–7277, E-mail address:

nmt1@cdc.gov.

To receive the document Innovative

Financing Sources for Lead Hazard

Control published by the Alliance to

End Childhood Lead Poisoning, or the

booklet on Community Reinvestment

Act (CRA), contact Nancy Tips.

(Address and number above.)

Joseph R. Carter,

Acting Associate Director for Management

and Operations, Centers for Disease Control

and Prevention (CDC).

[FR Doc. 98–15540 Filed 6–10–98; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

National Institute for Occupational

Safety and Health

[Announcement 98050]

A Young Worker Community-Based

Health Education Project Notice of

Availability of Funds for Fiscal Year

1998

Introduction

The Centers for Disease Control and

Prevention (CDC), the nation’s

prevention agency, announces the

availability of funds for fiscal year (FY)

1998 for a cooperative agreement

program which would consider and

utilize existing health education

materials and methods that address

young worker health issues.

Community-based education

intervention and its evaluation are the

core activities to be accomplished. This

project is related to the priority areas of

Special Populations and Intervention

Effectiveness Research in the National

Occupational Research Agenda.

CDC is committed to achieving the

health promotion and disease

prevention objectives of Healthy People

2000, a national activity to reduce

morbidity and mortality and improve

the quality of life. This announcement

is related to the priority area of

Occupational Safety and Health. (For

ordering a copy of Healthy People 2000,